Case Report: A “visceral vasculitis storm” in Systemic Lupus Erythematosus: simultaneous enteritis, ureteritis, and splenic infarction in a pediatric patient - Scorecard - MDSpire

Case Report: A “visceral vasculitis storm” in Systemic Lupus Erythematosus: simultaneous enteritis, ureteritis, and splenic infarction in a pediatric patient

  • By

  • Xia Wu

  • Yan Liu

  • Huan He

  • July 9, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: Concurrent Visceral Vasculitis Manifestations in Systemic Lupus Erythematosus: Enteritis, Ureteritis, and Splenic Infarction in a Pediatric Patient

At a Glance

CategoryDetail
ConditionSystemic Lupus Erythematosus (SLE)
Key MechanismsAutoimmune disease with multi-system involvement, characterized by autoantibody production and immune complex deposition.
Target PopulationPediatric patients with SLE presenting with visceral vasculitis.
Care SettingHospitalized care in nephrology and immunology departments.

Key Highlights

  • Lupus enteritis occurs in 0.2%-5.8% of SLE cases, while lupus ureteritis is exceedingly rare.
  • The case illustrates a 'visceral vasculitis storm' involving bowel, ureters, and spleen.
  • Ureteral wall enhancement on CECT may indicate primary lupus ureteritis.
  • The patient responded to methylprednisolone pulse therapy and IVIG.
  • Aggressive immunosuppressive therapy is essential to prevent irreversible organ damage.

Guideline-Based Recommendations

Diagnosis

  • Consider differential diagnoses including primary ureteritis vs. secondary mechanical compression.
  • Use CECT to identify ureteral wall enhancement as a diagnostic clue.

Management

  • Initiate aggressive immunosuppressive therapy promptly in cases of visceral vasculitis.

Monitoring & Follow-up

  • Monitor for signs of organ damage and response to immunosuppressive therapy.

Risks

  • Risk of irreversible organ damage if diagnosis and treatment are delayed.

Patient & Prescribing Data

Pediatric patients with SLE and concurrent visceral vasculitis manifestations.

Methylprednisolone pulse therapy followed by IVIG and maintenance therapy with Cyclophosphamide and Telitacicept.

Clinical Best Practices

  • Recognize the clinical complexity of simultaneous lupus enteritis and ureteritis.
  • Avoid diagnostic monism to ensure timely and appropriate treatment.

Related Resources & Content

Original Source(s)

Related Content